Baypamun HK

tradename; each ml (1 dose) HK contains inactivated parapox virus ovis with >4.4 million TCID50 (tissue culture infectious dose 50%); used in dogs & cats for immunization against parapox

Also Known As:

Networked: 10 relevant articles (4 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Barreca, F: 1 article (07/2000)
2.	Castrucci, G: 1 article (07/2000)
3.	Ferrari, M: 1 article (07/2000)
4.	Frigeri, F: 1 article (07/2000)
5.	Lo Dico, M: 1 article (07/2000)
6.	Osburn, B I: 1 article (07/2000)
7.	Salvatori, D: 1 article (07/2000)

Related Diseases

1.	Viremia 10/23/1998 - "Remission of viremia occurred in 12% and 7% of the cats treated with Baypamun and placebo, respectively. " 05/01/1997 - "Remission of the viremia occurred in 11.7% of the cats treated with Baypamun HK and in 6.7% of the cats treated with placebo. "
2.	Communicable Diseases (Infectious Diseases) 01/01/1989 - "The demonstration of the status of paramunity following Baypamun application in cattle provides a concept in the prevention of infectious disease in the practice." 01/01/1989 - "Efficacy of the paramunity inducer Baypamun (PIND-ORF) was evaluated by an IBR challenge trial in cattle, as one model for infectious diseases in bovine. "
3.	Infections 07/01/2000 - "All six calves were given Baypamun at various times following the exposure to BHV-1 infection and all showed a much reduced reaction with two treated for 4 days developing no clinical disease. " 09/01/1999 - "Since that time, Baypamun is the most commonly used drug for treatment of FeLV infection in Germany and other European countries. " 10/23/1998 - "Therefore, FeLV infection was not influenced by Baypamun treatment." 05/01/1995 - "Since 1988 in order to protect animals against infections IBR negative cattle and cows on 7 regional, one national and one international exhibitions were treated with Duphamun and Baypamun, respectively. " 02/01/1995 - "The 8 calves all became infected but those that had been treated with Baypamun did not show any clinical signs of the disease, whereas the untreated calves underwent a clinical response which was considered to be typical of BHV-1 respiratory infection, as usually seen under natural conditions. "
4.	Respiratory Tract Infections (Respiratory Tract Infection) 02/01/1993 - "During the observation period of three weeks, beginning with the first and ending ten days after the last application, 7.9% of the foals treated with Baypamun (3 out of 38) suffered from respiratory infections compared to 24% of the foals treated with placebo (6 out of 25). "
5.	Infectious Bovine Rhinotracheitis 07/01/2000 - "Three experiments have been carried out to verify the effectiveness of an immunomodulator, Baypamun (Bayer AG) in limiting the spread of Bovine herpesvirus-1 (BHV-1), the causal agent of infectious bovine rhinotracheitis (IBR). "

Related Drugs and Biologics

1.	PIND-ORF
2.	Immunologic Factors (Immunomodulators)
3.	Vaccines
4.	Interferons